labetalol has been researched along with atenolol in 111 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 53 (47.75) | 18.7374 |
| 1990's | 16 (14.41) | 18.2507 |
| 2000's | 20 (18.02) | 29.6817 |
| 2010's | 16 (14.41) | 24.3611 |
| 2020's | 6 (5.41) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Faller, B; Wohnsland, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Baker, JG | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Crawford, DH; Fletcher, LM; Li, P; Roberts, MS; Robertson, TA; Thorling, CA; Zhang, Q | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chang, Q; Chen, Z; Hu, G; Hu, L; Li, Q; Long, J | 1 |
| Esaki, T; Kawashima, H; Komura, H; Kuroda, M; Mizuguchi, K; Natsume-Kitatani, Y; Ohashi, R; Watanabe, R | 1 |
| Wilcox, RG | 1 |
| Louis, WJ; McNeil, JJ | 1 |
| Goldberg, SR; Schindler, CW; Tella, SR | 1 |
| Demopoulos, CA; Kapoulas, VM; Tsangaris, GT; Tsoukatos, DC | 1 |
| Mills, RG; Roberts, MS; Shen, JJ; Wanwimolruk, S | 1 |
| Leloux, MS; Niessen, WM; van der Hoeven, RA | 1 |
| Bilić, A; Ljubicić, N | 1 |
| DiPette, DJ; Goodman, RP; McKenney, JM; Townsend, R; Wright, JT | 1 |
| Davidson, JM; Maurice, J; Richardson, R; Smith, ER; Walter, T | 1 |
| Bowles, MJ; Glover, DR; Smith, L | 1 |
| Boulet, LP; Lacourcière, Y; Lampron, N; Milot, J | 1 |
| Campbell, DM; Cruickshank, DJ | 1 |
| Blumfield, D; Cronin, R; DiPette, DJ; Goodman, R; Gradman, A; Katz, LA; McCarthy, EP; Sopko, G; Townsend, RR | 1 |
| Ebihara, A; Fujimura, A; Kotegawa, T | 1 |
| Silke, B; Taylor, SH; Tham, TC | 1 |
| Cornman, C; Dianzumba, SB; DiPette, D; Joyner, CR; Mauro, K; Theobald, T; Townsend, R; Weber, E | 1 |
| Opie, LH | 1 |
| Frishman, WH; Glasser, SP; Liebson, P; Poland, MP; Schoenberger, JA; Strom, JA | 1 |
| Hedner, J; Lemne, C; Svedmyr, N; Ullman, A | 1 |
| Atkins, J; Bugni, W; Cubbon, J; Fouad-Tarazi, F; Poland, MP; Strom, JA; Vidt, DG | 1 |
| Avolio, A; Daley, J; Kelly, R; O'Rourke, M | 1 |
| Carrageta, MO; Raftery, EB | 1 |
| Brunn, PW; Cook, D; Judy, W; Ryder, KW; Schulz, AR; Steinrauf, LK | 1 |
| Calder, AA; Forbes, CD; Greer, IA; McLaren, M; Walker, JJ | 1 |
| Fishbein, L; Jackson, CD | 1 |
| Cumetti, C; De Cristofaro, A; Montanari, C; Roja, M; Vergani, A | 1 |
| Epstein, M; Oster, JR | 1 |
| Dal Negro, RW; Pomari, C; Trevisan, F; Turco, P; Zoccatelli, O | 1 |
| Mwongera, FM; Raman, GV; Warren, DJ | 1 |
| Iwasaki, S; Kizawa, Y; Nakagoshi, A; Takayanagi, I | 1 |
| Breckenridge, AM; Grimmer, SF; Orme, ML; Roberts, DH; Tsao, Y; Winstanley, PA | 1 |
| Pandhi, P; Sharma, PL | 1 |
| Breckenridge, A; McLoughlin, GA; Roberts, DH; Tsao, Y | 1 |
| Foëx, P; Johnson, LL; Khambatta, HJ; Sear, JW; Stone, JG; Triner, L | 1 |
| Proegler, M; Schneider, H | 1 |
| Viinikka, L; Ylikorkala, O | 1 |
| Qvigstad, EK; Schamaun, O; Teisberg, P; Westheim, A | 1 |
| Cornman, C; Dianzumba, SB; DiPette, D; Joyner, CR; Mauro, K; Townsend, R; Weber, E | 1 |
| Clifton, GG; Cook, ME; Poland, M; Wallin, JD | 1 |
| Berry, DA; Finley, D; Holtzman, JL; Johnson, B; Sirgo, MA | 1 |
| Avantaggiato, F; Balestrazzi, M; Chiarappa, R; De Cesaris, R; Grimaldi, A; Ranieri, G | 1 |
| Donker, AJ; May, JF; Schuurman, FH; ten Berge, BS; van der Veur, E; Wesseling, H | 1 |
| Jee, LD; Opie, LH | 1 |
| Calder, AA; Forbes, CD; Greer, IA; Walker, JJ | 1 |
| ten Berge, BS; van der Veur, E; Wesseling, H; Wouda, AA | 1 |
| Dean, S; Jack, DB; Kendall, MJ; Laugher, S | 1 |
| Adam, WR; Barter, CE; Meagher, EJ | 1 |
| Smith, AM | 1 |
| Bonduelle, M; Calder, AA; Greer, I; Walker, H | 1 |
| Charyev, KhE; Erina, EV | 1 |
| Desiatnichenko, VM; Romakov, AIu; Sagirov, AM; Sobol', IuS; Sumarokov, AB | 1 |
| Blazquez, G; Flouvat, B; Gerard, J; Lardoux, H | 1 |
| Johns, VJ | 1 |
| Cherenshchikova, EA; Filippov, AK; Iuzhakov, SD; Mashkovskiĭ, MD; Porotikov, VI | 1 |
| Chung, DC; Laschuk, MJ | 1 |
| Baldwin, CJ; Gribbin, HR; Mackay, AD; Tattersfield, AE | 1 |
| Cuisinaud, G; Pozet, N; Sassard, J; Vincent, M; Zech, PY | 1 |
| Latham, L; Lorimer, AR; McAreavey, D; McLaren, AD; Ramsey, LE; Reid, JL; Robertson, JI; Robertson, MP; Weir, RJ | 1 |
| Amery, A; Cattaert, A; Fagard, R; Grauwels, R; Reybrouck, T; Vanhees, L; Vanmeenen, T | 1 |
| Galletly, DC; Maling, TJ; Yee, P | 1 |
| Blazquez, G; Chouty, F; Flouvat, B; Gerard, J; Lardoux, H | 1 |
| Beauséjour, B; Blazquez, G; Faurie, C; Flouvat, B; Gérard, J; Lardoux, H; Rousset, D | 1 |
| Henningsen, NC; Karlberg, BE; Nilsson, OR; Thulin, T | 1 |
| Beevers, DG; Jackson, SH | 1 |
| Amery, A; Fagard, R; Lijnen, P; Reybrouck, T | 1 |
| Daneshmend, TK; Roberts, CJ | 1 |
| Balasubramanian, V; Mann, S; Millar-Craig, MW; Raftery, EB | 1 |
| Dahiya, SS; Seth, RK; Seth, S; Sharma, D; Siwach, SB | 1 |
| Kemp, GJ; Odoom, JE; Radda, GK | 1 |
| Lind, L; Millgård, J; von zur Můhlen, B | 1 |
| Chen, IJ; Chiang, LC; Chiu, CC; Liang, JC; Lin, YT; Tsai, CH; Wu, JR; Yeh, JL | 1 |
| Rollins, G | 1 |
| de Mol, BA; Jacobs, MJ; Meijboom, LJ; Mulder, BJ; Nollen, GJ; Spaan, JA; Westerhof, BE | 1 |
| Asadpour-Zeynali, K; Jouyban, A; Majidi, MR | 1 |
| Abdine, H; Belal, F; Hefnawy, MM; Sultan, MA | 1 |
| Weber, MA | 1 |
| Cockcroft, JR; Pedersen, ME | 1 |
| Cleper, R; Davidovits, M; Kovalski, Y; Krause, I; Sinai, L | 1 |
| Campos, I; Costa, F; Gonçalves, P; Keating, E; Martel, F | 1 |
| Crawford, DH; Fletcher, LM; Li, P; Roberts, MS; Robertson, TA; Weiss, M; Zhang, Q | 1 |
| Freundlich, RE; Kheterpal, S; Mashour, GA; Matlen, L; Merte, J; Nallamothu, BK; Shanks, A; Sharifpour, M; Tremper, KK; Vlisides, PE; Weightman, A | 1 |
| Castro Jiménez, A; Feo-Brito, F; García Rodríguez, C; García Rodríguez, R; Gómez Torrijos, E; Sánchez Caminero, MP | 1 |
| Bateman, BT; Desai, RJ; Fischer, MA; Hernandez-Diaz, S; Huybrechts, KF; Maeda, A; Mogun, H; Patorno, E; Seely, EW | 1 |
| Chen, W; Duan, L; Lee, MS; Ng, A; Nguyen, J; Shen, AY; Spencer, HT | 1 |
| Chen, W; Duan, L; Lee, MS; Ng, A; Spencer, HT | 1 |
| Ansorge, M; Dovhunová, M; Galić, N; Habinovec, I; Pocrnić, M; Tesařová, E | 1 |
| Jacobsen, SJ; Kalantar-Zadeh, K; Kovesdy, CP; Lee, MS; Neyer, JR; Shaw, SF; Shi, J; Sim, JJ; Zhou, H | 1 |
| Ballotari, M; Gottardo, R; Tagliaro, F; Taus, F; Utzeri, C | 1 |
| Carlo, MJ; Patrick, AL | 1 |
8 review(s) available for labetalol and atenolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Hypertension and beta-blockers. Are they all the same?
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Circadian Rhythm; Humans; Hypertension; Labetalol; Metoprolol; Pindolol; Receptors, Adrenergic, alpha; Sotalol | 1985 |
A toxicological review of beta-adrenergic blockers.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol | 1986 |
Beta blockers and renal function: a reappraisal.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Urea Nitrogen; Cardiac Output; Creatinine; Dogs; Glomerular Filtration Rate; Heart; Humans; Hypertension; Kidney; Labetalol; Metoprolol; Nadolol; Propanolamines; Propranolol; Renal Circulation; Renin; Sympathomimetics; Vascular Resistance | 1985 |
Beta-blocking drugs for arrhythmias, hypertension, and ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Arrhythmias, Cardiac; Atenolol; Blood Pressure; Coronary Disease; Dogs; Heart Rate; Humans; Hypertension; Labetalol; Myocardial Infarction; Propranolol | 1984 |
The new beta-adrenergic antagonists.
Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Labetalol; Metoprolol; Nadolol; Oxprenolol; Pindolol; Propanolamines; Timolol | 1984 |
The role of the new beta-blockers in treating cardiovascular disease.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Benzopyrans; Cardiovascular Diseases; Clinical Trials as Topic; Enalapril; Ethanolamines; Female; Heart Failure; Hemodynamics; Humans; Hypertension; Labetalol; Losartan; Male; Metoprolol; Middle Aged; Nebivolol; Nifedipine; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Sympathomimetics | 2005 |
The vasodilatory beta-blockers.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Antioxidants; Atenolol; Benzopyrans; Blood Pressure; Carbazoles; Cardiac Output; Cardiovascular Diseases; Carvedilol; Endothelium, Vascular; Ethanolamines; Hemodynamics; Humans; Labetalol; Nebivolol; Propanolamines; Vascular Resistance; Vasodilation; Ventricular Function, Left | 2007 |
34 trial(s) available for labetalol and atenolol
| Article | Year |
|---|---|
Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Bendroflumethiazide; Clinical Trials as Topic; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Pindolol; Propranolol; Random Allocation; Timolol | 1978 |
A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Metoprolol; Middle Aged; Pindolol; Time Factors | 1979 |
The effects of selective and non-selective adrenoceptor blockade on the portal blood flow in patients with liver cirrhosis.
Topics: Adult; Analysis of Variance; Atenolol; Blood Flow Velocity; Female; Humans; Labetalol; Liver Cirrhosis; Male; Middle Aged; Portal System; Propranolol; Sympatholytics; Ultrasonography | 1991 |
Renin profile, race, and antihypertensive efficacy with atenolol and labetalol.
Topics: Atenolol; Black People; Blood Pressure; Double-Blind Method; Humans; Hypertension; Labetalol; Middle Aged; Renin; White People | 1991 |
Randomised, double-blind, three-way cross-over study of dilevalol 200 and 400 mg and atenolol 100 mg once-daily in patients with chronic stable angina pectoris.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Angina Pectoris; Atenolol; Blood Pressure; Chronic Disease; Double-Blind Method; Exercise Test; Heart Rate; Humans; Labetalol; Male; Middle Aged; Randomized Controlled Trials as Topic | 1990 |
Comparative effects of dilevalol and atenolol on lung function and airway response to methacholine in hypertensive subjects.
Topics: Adult; Aged; Atenolol; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Hypertension; Labetalol; Lung; Male; Methacholine Compounds; Middle Aged; Peak Expiratory Flow Rate; Randomized Controlled Trials as Topic; Respiratory Function Tests; Respiratory System; Vital Capacity | 1990 |
Atenolol in essential hypertension during pregnancy.
Topics: Atenolol; Female; Fetal Growth Retardation; Humans; Hypertension; Labetalol; Pregnancy; Pregnancy Complications, Cardiovascular | 1990 |
Combined alpha/beta-blockade versus beta 1-selective blockade in essential hypertension in black and white patients.
Topics: Atenolol; Black People; Blood Pressure; Double-Blind Method; Heart Rate; Humans; Hypertension; Labetalol; Prospective Studies; White People | 1990 |
Clinical pharmacology of dilevalol (i.v.). Influence of hepatic and renal functions on the disposition of dilevalol and atenolol in hypertensive subjects.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Atenolol; Female; Humans; Hypertension; Kidney; Labetalol; Liver; Male; Middle Aged; Random Allocation; Single-Blind Method; Time Factors | 1990 |
Comparison of central and peripheral haemodynamic effects of dilevalol and atenolol in essential hypertension.
Topics: Analysis of Variance; Atenolol; Blood Flow Velocity; Blood Pressure; Cardiac Output; Echocardiography, Doppler; Heart Rate; Hemodynamics; Humans; Hypertension; Labetalol; Middle Aged; Thermography; Vascular Resistance | 1990 |
Left ventricular filling in hypertensive blacks and whites following adrenergic blockade.
Topics: Adult; Analysis of Variance; Atenolol; Black People; Cardiac Volume; Diastole; Double-Blind Method; Echocardiography, Doppler; Female; Heart Ventricles; Humans; Hypertension; Labetalol; Male; Middle Aged; Randomized Controlled Trials as Topic; United States; White People | 1990 |
Effects of dilevalol, metoprolol and atenolol on left ventricular mass and function in nonelderly and elderly hypertensive patients.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Double-Blind Method; Echocardiography; Female; Heart; Heart Rate; Humans; Hypertension; Labetalol; Male; Metoprolol; Middle Aged; Random Allocation; Stroke Volume; Supination | 1989 |
Effects of dilevalol, a beta-adrenoceptor antagonist with intrinsic sympathetic activity in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Asthma; Atenolol; Double-Blind Method; Female; Forced Expiratory Volume; Hemodynamics; Humans; Labetalol; Male; Middle Aged; Terbutaline; Tremor; Vital Capacity | 1989 |
Arterial dilation and reduced wave reflection. Benefit of dilevalol in hypertension.
Topics: Adult; Aged; Aorta; Arteries; Atenolol; Blood Pressure; Brachial Artery; Carotid Arteries; Extremities; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Vasodilation | 1989 |
Respiratory effects of four adrenergic blocking agents combined with a diuretic in treating hypertension with concurrent chronic obstructive lung disease.
Topics: Adrenergic beta-Antagonists; Airway Resistance; Atenolol; Chlorthalidone; Drug Therapy, Combination; Forced Expiratory Volume; Humans; Hypertension; Labetalol; Lung Diseases, Obstructive; Male; Maximal Midexpiratory Flow Rate; Metoprolol; Oxprenolol; Random Allocation | 1986 |
Comparison of the effects of atenolol, sotalol and labetalol on muscle blood flow in man.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Double-Blind Method; Humans; Labetalol; Male; Muscles; Physical Exertion; Regional Blood Flow; Sotalol | 1986 |
Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Captopril; Female; Forearm; Heart; Heart Rate; Hemodynamics; Humans; Hypertension; Labetalol; Leg; Male; Middle Aged; Myocardial Contraction; Pindolol; Regional Blood Flow; Vascular Resistance | 1987 |
Comparative effects of beta-, alpha- and combined beta- plus alpha-adrenoceptor blocking agents in stress-induced increase in arterial blood pressure.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Cold Temperature; Double-Blind Method; Heart Rate; Humans; Isometric Contraction; Labetalol; Male; Prazosin; Propranolol; Random Allocation; Stress, Physiological | 1987 |
Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication.
Topics: Atenolol; Blood Pressure; Captopril; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Heart Rate; Humans; Hypertension; Intermittent Claudication; Labetalol; Leg; Male; Middle Aged; Pindolol; Random Allocation | 1987 |
Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Anesthesia; Atenolol; Clinical Trials as Topic; Coronary Disease; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Oxprenolol; Preanesthetic Medication; Random Allocation | 1988 |
A comparative study on the effect of atenolol and labetalol on exercise capacity and lipid serum levels in essential hypertension.
Topics: Adult; Atenolol; Clinical Trials as Topic; Combined Modality Therapy; Exercise Test; Female; Humans; Hypertension; Labetalol; Lipids; Male; Middle Aged | 1987 |
Left ventricular function in mild hypertension after adrenergic blockade.
Topics: Atenolol; Double-Blind Method; Echocardiography; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Myocardial Contraction; Random Allocation | 1988 |
Renal function effects of dilevalol, a nonselective beta-adrenergic blocking drug with beta-2 agonist activity.
Topics: Administration, Oral; Adult; Aged; Atenolol; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Kidney Function Tests; Labetalol; Male; Metoprolol; Middle Aged | 1988 |
The effects of single-dose atenolol, labetalol, and propranolol on cardiac and vascular function.
Topics: Aged; Atenolol; Cardiac Output; Cardiovascular System; Heart Rate; Humans; Hypertension; Labetalol; Male; Middle Aged; Propranolol; Vascular Resistance | 1986 |
A comparison of labetalol and prazosin combined with atenolol in non-responders to atenolol plus hydrochlorothiazide in uncomplicated hypertension.
Topics: Adult; Atenolol; Chlorothiazide; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Prazosin; Random Allocation; Time Factors | 1985 |
Double-blind trial comparing labetalol with atenolol in the treatment of systemic hypertension with angina pectoris.
Topics: Adult; Angina Pectoris; Atenolol; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; Heart Rate; Humans; Hypertension; Labetalol; Male; Middle Aged; Nitroglycerin; Physical Exertion | 1985 |
Effects of atenolol, labetalol and propranolol on the peripheral circulation in hypertensive patients without obstructive vascular disease.
Topics: Adolescent; Adult; Atenolol; Blood Circulation; Ethanolamines; Female; Fingers; Humans; Hypertension; Labetalol; Male; Middle Aged; Plethysmography; Propranolol; Regional Blood Flow | 1985 |
Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Ethanolamines; Humans; Hypertension; Labetalol; Lung Diseases, Obstructive; Lung Volume Measurements; Metoprolol; Middle Aged; Propranolol | 1982 |
Antihypertensive therapy in pregnancy.
Topics: Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Labetalol; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Cardiovascular; Propanolamines; Random Allocation | 1983 |
[Comparative evaluation of the therapeutic effect of various classes of beta-blockaders in patients with hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Echocardiography; Heart; Hemodynamics; Humans; Hypertension; Labetalol; Middle Aged; Nadolol; Propanolamines; Propranolol | 1983 |
"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Methyldopa; Middle Aged; Minoxidil; Prazosin | 1984 |
Antihypertensive and metabolic effects of increasing doses of atenolol and labetalol. A comparative study in primary hypertension.
Topics: Adult; Aged; Aldosterone; Atenolol; Blood Pressure; Double-Blind Method; Drug Evaluation; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Propanolamines; Random Allocation; Renin | 1982 |
Comparison of the effects of single doses of atenolol and labetalol on airways obstruction in patients with hypertension and asthma.
Topics: Adult; Asthma; Atenolol; Blood Pressure; Ethanolamines; Female; Forced Expiratory Volume; Humans; Hypertension; Labetalol; Lung Diseases, Obstructive; Male; Middle Aged; Propanolamines; Pulse | 1983 |
Effect of atenolol and labetalol on serum lipids.
Topics: Atenolol; Female; Humans; Hyperlipidemias; Hypertension; Labetalol; Lipids; Male | 1993 |
69 other study(ies) available for labetalol and atenolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
Topics: Alkanes; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Octanols; Permeability; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Cations; Cytochrome P-450 Enzyme System; Disease Models, Animal; Emulsions; Fats; Fatty Liver; Liver; Liver Cirrhosis; Male; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Melanoma; Molecular Docking Simulation; Molecular Structure; Propanols; Skin Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
Development of an
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Cell Line; Computer Simulation; Endothelial Cells; Gene Knockout Techniques; Humans; Organic Chemicals; Rats, Transgenic | 2021 |
Adrenoceptor mechanisms in the cardiovascular effects of cocaine in conscious squirrel monkeys.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Cocaine; Heart Rate; Labetalol; Male; Phentolamine; Prazosin; Propanolamines; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Saimiri; Yohimbine | 1992 |
Study of the glycogenolytic action of platelet activating factor in Tetrahymena pyriformis.
Topics: Animals; Atenolol; Calcium; Cyclic AMP; Glucose; Glycogen; Labetalol; Platelet Activating Factor; Propranolol; Tetrahymena pyriformis | 1992 |
Response to beta-blockers in maternal and fetal rat hearts in vitro.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Female; Heart; Heart Rate; Isoproterenol; Labetalol; Metoprolol; Pregnancy; Pregnancy, Animal; Propranolol; Rats; Rats, Inbred Strains | 1991 |
Thermospray liquid chromatography/mass spectrometry of polar beta-blocking drugs: preliminary results.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Gas Chromatography-Mass Spectrometry; Humans; In Vitro Techniques; Labetalol; Sotalol | 1991 |
Effects of four beta-adrenergic receptor antagonists on male rat sexual behavior.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Dose-Response Relationship, Drug; Labetalol; Male; Pindolol; Propranolol; Rats; Sexual Behavior, Animal | 1990 |
Mechanism of smooth muscle contraction: relevance to safety of beta-adrenergic blockade in hypertensive patients with reversible chronic obstructive airways disease.
Topics: Adrenergic beta-Antagonists; Atenolol; Bronchi; Calcium Channel Blockers; Calmodulin; Celiprolol; Cyclic AMP; Heart; Humans; Hypertension; Labetalol; Lung Diseases, Obstructive; Models, Biological; Muscle Contraction; Muscle, Smooth; Myosins; Phosphorylation; Propanolamines | 1986 |
Mechanism of antihypertensive action of dilevalol compared with that of "cardioselective" beta-blocking agents.
Topics: Adult; Aged; Atenolol; Female; Heart; Heart Rate; Humans; Hypertension; Labetalol; Male; Metoprolol; Middle Aged; Stroke Volume; Vascular Resistance | 1989 |
Beta-adrenergic blocking agents. Effect of chronic dosage on a fit, middle-aged man: a case study and review.
Topics: Adrenergic beta-Antagonists; Atenolol; Energy Metabolism; Ethanolamines; Exercise Test; Hemodynamics; Humans; Hypertension; Labetalol; Male; Middle Aged | 1985 |
Inhibition of thromboxane and prostacyclin production in whole blood by adrenoceptor antagonists.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Atenolol; Epoprostenol; Humans; Labetalol; Pindolol; Propranolol; Thromboxane A2; Thromboxane B2 | 1985 |
Antihypertensive therapy with diuretics and beta-blockers at fixed dosage: comparison between the combinations labetalol plus chlorthalidone and atenolol plus chlorthalidone.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Chlorthalidone; Diuretics; Drug Therapy, Combination; Exercise Test; Heart Rate; Humans; Hypertension; Labetalol; Male | 1985 |
(+/-)-1-[[2-(3,4-Dimethoxphenyl)ethyl]amino]-3-(3-methylphenoxy)-2- propanol hydrochloride (bevantolol, NC-1400) as a beta 1-selective adrenoceptor blocker with alpha 1-adrenoceptor blocking activity.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Guinea Pigs; In Vitro Techniques; Labetalol; Male; Muscle Contraction; Muscle, Smooth; Propanolamines; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1987 |
Placental transfer of beta-adrenergic antagonists studied in an in vitro perfusion system of human placental tissue.
Topics: Adrenergic beta-Antagonists; Atenolol; Celiprolol; Female; Humans; In Vitro Techniques; Labetalol; Maternal-Fetal Exchange; Placenta; Pregnancy; Propanolamines; Propranolol; Timolol | 1988 |
Beta blockers inhibit fetal thromboxane A2 production in vitro.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Platelets; Female; Fetal Blood; Humans; Infant, Newborn; Kinetics; Labetalol; Metoprolol; Pregnancy; Propranolol; Thromboxane A2 | 1988 |
Changes in blood pressure and thermographic values resulting from use of a beta-blocker plus diuretic and of an alpha-beta-blocker plus diuretic.
Topics: Adult; Atenolol; Body Temperature; Chlorthalidone; Drug Therapy, Combination; Heart Rate; Humans; Hypertension; Labetalol; Middle Aged; Thermography | 1985 |
Inhibition of platelet aggregation in whole blood by adrenoceptor antagonists.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Atenolol; Collagen; Drug Synergism; Epoprostenol; Humans; Labetalol; Pindolol; Platelet Aggregation; Propranolol; Solubility; Sympatholytics | 1985 |
Detection of some antihypertensive drugs and their metabolites in urine by thin-layer chromatography: II. A further five beta blockers and dihydralazine.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Chromatography, Thin Layer; Dihydralazine; Humans; Hypertension; Labetalol; Sotalol | 1980 |
Beta-blockers for pregnancy hypertension.
Topics: Adrenergic beta-Antagonists; Atenolol; Female; Humans; Hypertension; Labetalol; Pregnancy; Pregnancy Complications, Cardiovascular | 1983 |
[Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Atenolol; Echocardiography; Exercise Test; Hemodynamics; Humans; Labetalol; Male; Middle Aged; Nadolol; Propanolamines; Propranolol | 1983 |
Which beta-blocker in pregnancy-induced hypertension?
Topics: Atenolol; Birth Weight; Ethanolamines; Female; Humans; Hypertension; Infant, Newborn; Labetalol; Pregnancy; Pregnancy Complications, Cardiovascular | 1983 |
[Role of transmembrane ion currents in the mechanism of action of beta-adrenoblockers].
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Heart; Ion Channels; Labetalol; Oxprenolol; Pindolol; Propranolol; Rana ridibunda | 1984 |
Bronchial and cardiac beta-adrenoceptor blockade--a comparison of atenolol, acebutolol and labetalol.
Topics: Acebutolol; Airway Resistance; Atenolol; Bronchi; Dose-Response Relationship, Drug; Ethanolamines; Heart; Heart Rate; Humans; Labetalol; Physical Exertion; Propanolamines; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1981 |
[Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
Topics: Adult; Atenolol; Blood Pressure; Ethanolamines; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Labetalol; Male; Renin; Time Factors | 1983 |
The effects of beta blockers on exercise capacity and on training response in elderly subjects.
Topics: Aged; Atenolol; Coronary Disease; Ethanolamines; Exercise Test; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Physical Education and Training; Physical Exertion | 1984 |
Anaesthetic management of combined caesarean section and phaeochromocytoma removal.
Topics: Adrenal Gland Neoplasms; Adult; Anesthesia, General; Atenolol; Cesarean Section; Female; Humans; Labetalol; Nitrous Oxide; Pancuronium; Phentolamine; Pheochromocytoma; Preanesthetic Medication; Pregnancy; Pregnancy Complications, Neoplastic | 1983 |
Hypertension in pregnancy: evaluation of two beta blockers atenolol and labetalol.
Topics: Adolescent; Adult; Atenolol; Ethanolamines; Female; Fetus; Humans; Hypertension; Infant, Newborn; Labetalol; Labor, Obstetric; Middle Aged; Pregnancy; Pregnancy Complications, Cardiovascular | 1983 |
[Effect of 2 beta-blockers on arterial hypertension during pregnancy. Results of a prospective study on 56 pregnant hypertensive women treated with atenolol and labetalol].
Topics: Adolescent; Adult; Atenolol; Delivery, Obstetric; Ethanolamines; Female; Fetal Heart; Fetal Monitoring; Heart Rate; Humans; Hypertension; Labetalol; Labor, Obstetric; Middle Aged; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Proteinuria | 1983 |
Role of the renin-angiotensin and of the adrenergic system in the blood pressure regulation at exercise in normotensive subjects and in hypertensive patients.
Topics: Adaptation, Physiological; Atenolol; Blood Pressure; Brachial Artery; Hemodynamics; Humans; Hypertension; Labetalol; Oxygen; Oxygen Consumption; Physical Exertion; Pulmonary Artery; Pulmonary Wedge Pressure; Renin; Renin-Angiotensin System; Sympathetic Nervous System | 1981 |
The short term effects of propranolol, atenolol and labetalol on antipyrine kinetics in normal subjects.
Topics: Adult; Antipyrine; Atenolol; Drug Interactions; Female; Half-Life; Humans; Kinetics; Labetalol; Male; Propranolol; Sympatholytics | 1982 |
Effects of treatment on circadian rhythms of blood pressure.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Circadian Rhythm; Heart Rate; Humans; Hypertension; Labetalol; Metoprolol; Oxprenolol | 1981 |
The regulation of total creatine content in a myoblast cell line.
Topics: Animals; Atenolol; Bucladesine; Butoxamine; Cell Line; Clenbuterol; Creatine; Energy Metabolism; Insulin; Insulin-Like Growth Factor I; Isoproterenol; Labetalol; Methoxamine; Mice; Muscle, Skeletal; Norepinephrine; Phentolamine; Propranolol; Sodium; Triiodothyronine | 1996 |
Divergent effects of different beta-blocking agents on endothelium-dependent vasodilatation in the human forearm.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Atenolol; Blood Pressure; Diclofenac; Endothelium, Vascular; Female; Forearm; Heart Rate; Humans; Injections, Intra-Arterial; Labetalol; Male; Methacholine Chloride; Nitroprusside; Plethysmography; Propranolol; Receptors, Adrenergic, alpha-1; Receptors, Muscarinic; Vasodilation; Vasodilator Agents | 2000 |
Pharmacological effects of an aldehyde type alpha/beta-adrenoceptor blocking agent with vasodilating properties.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Aorta; Atenolol; Benzaldehydes; Blood Pressure; Cardiovascular Agents; Depression, Chemical; Dose-Response Relationship, Drug; Guinea Pigs; Heart Atria; Heart Rate; Isoproterenol; Labetalol; Mecamylamine; Models, Animal; Muscle, Smooth, Vascular; Myocardial Contraction; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Regression Analysis; Stimulation, Chemical; Vasodilator Agents | 2000 |
Guidelines on high blood pressure in pregnancy give new classifications of disease.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Contraindications; Female; Humans; Hypertension; Labetalol; Methyldopa; Practice Guidelines as Topic; Pre-Eclampsia; Pregnancy; United States | 2000 |
Beta-blocking therapy in patients with the Marfan syndrome and entire aortic replacement.
Topics: Adrenergic beta-Antagonists; Adult; Aorta; Atenolol; Blood Pressure; Blood Vessel Prosthesis Implantation; Case-Control Studies; Female; Humans; Labetalol; Magnetic Resonance Imaging; Male; Marfan Syndrome; Postoperative Care; Pulsatile Flow | 2004 |
Modeling the electrophoretic mobility of beta-blockers in capillary electrophoresis using artificial neural networks.
Topics: Adrenergic beta-Antagonists; Atenolol; Electrolytes; Electrophoresis, Capillary; Electrophoretic Mobility Shift Assay; Labetalol; Models, Chemical; Neural Networks, Computer; Pharmaceutical Preparations; Practolol; Predictive Value of Tests; Propranolol; Solvents; Technology, Pharmaceutical; Timolol | 2005 |
Spectrofluorometric determination of some beta-blockers in tablets and human plasma using 9,10-dimethoxyanthracene-2-sodium sulfonate.
Topics: Adrenergic beta-Antagonists; Anthracenes; Atenolol; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Labetalol; Propanolamines; Reference Standards; Spectrometry, Fluorescence; Tablets | 2005 |
Changes in behavior as an early symptom of renovascular hypertension in children.
Topics: Angiography; Antihypertensive Agents; Atenolol; Attention Deficit Disorder with Hyperactivity; Child Behavior Disorders; Child, Preschool; Female; Follow-Up Studies; Humans; Hypertension, Renovascular; Labetalol; Nifedipine; Renal Artery; Retrospective Studies; Time Factors; Treatment Outcome; Vasodilator Agents | 2009 |
Folic acid uptake by the human syncytiotrophoblast: interference by pharmacotherapy, drugs of abuse and pathological conditions.
Topics: Amphetamine; Antihypertensive Agents; Atenolol; Biological Transport; Cell Survival; Cells, Cultured; Diabetes Mellitus; Dose-Response Relationship, Drug; Dronabinol; Eclampsia; Ethanol; Female; Folic Acid; Gene Expression; Glucose; Humans; Hydrogen-Ion Concentration; Hypoglycemic Agents; Illicit Drugs; Insulin; Kinetics; Labetalol; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Pregnancy; Trophoblasts | 2009 |
Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.
Topics: Adrenergic Antagonists; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Atenolol; Cell Membrane Permeability; Cytochrome P-450 Enzyme System; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Heart Failure; Labetalol; Linear Models; Liver; Liver Cirrhosis; Liver Diseases; Male; Metabolic Clearance Rate; Metoprolol; Microsomes, Liver; Models, Biological; Necrosis; Nonlinear Dynamics; Perfusion; Propranolol; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction | 2012 |
Perioperative metoprolol and risk of stroke after noncardiac surgery.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Analysis of Variance; Atenolol; Cohort Studies; Data Interpretation, Statistical; Female; Humans; Incidence; Labetalol; Logistic Models; Male; Metoprolol; Middle Aged; Monitoring, Intraoperative; Odds Ratio; Postoperative Complications; Propanolamines; Retrospective Studies; Risk Factors; Stroke; Treatment Outcome; Young Adult | 2013 |
First case report of acute generalized exanthematous pustulosis due to labetalol.
Topics: Acute Generalized Exanthematous Pustulosis; Adrenergic Antagonists; Adult; Antihypertensive Agents; Atenolol; Cross Reactions; Drug Substitution; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Patch Tests; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, Third | 2015 |
Late Pregnancy β Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia.
Topics: Adrenergic beta-Antagonists; Atenolol; Bradycardia; Cohort Studies; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Hypoglycemia; Infant, Newborn; Infant, Newborn, Diseases; Labetalol; Male; Maternal Exposure; Metoprolol; Pregnancy; Pregnancy Complications, Cardiovascular; Propensity Score | 2016 |
β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.
Topics: Adrenergic beta-Antagonists; Age Factors; Arrhythmias, Cardiac; Atenolol; Body Mass Index; California; Cohort Studies; Confounding Factors, Epidemiologic; Diabetes Mellitus; Eclampsia; Female; Gestational Age; Heart Defects, Congenital; Heart Failure; Humans; Hyperlipidemias; Hypertension; Labetalol; Logistic Models; Metoprolol; Multivariate Analysis; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Propranolol; Retrospective Studies; Risk; Risk Factors | 2017 |
Beta-blocker subtypes and risk of low birth weight in newborns.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Atenolol; Birth Weight; California; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Infant, Small for Gestational Age; Labetalol; Male; Metoprolol; Pregnancy; Prevalence; Propranolol; Retrospective Studies | 2018 |
Chiral separation of beta-blockers by high-performance liquid chromatography and determination of bisoprolol enantiomers in surface waters.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Chromatography, High Pressure Liquid; Labetalol; Metoprolol; Water | 2020 |
β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atenolol; Bisoprolol; Carvedilol; Cause of Death; Cohort Studies; Female; Heart Failure; Hospitalization; Humans; Kidney Failure, Chronic; Labetalol; Logistic Models; Male; Metoprolol; Middle Aged; Mortality; Nadolol; Proportional Hazards Models; Propranolol; Protective Factors; Renal Dialysis; Retrospective Studies; Risk; Risk Factors | 2021 |
Hair analysis for beta-blockers and calcium-channel blockers by using liquid chromatography-tandem mass spectrometry as a tool for monitoring adherence to antihypertensive therapy.
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Bisoprolol; Calcium; Calcium Channel Blockers; Chromatography, Liquid; Hair Analysis; Humans; Labetalol; Metoprolol; Nadolol; Nebivolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry | 2022 |
Further exploration of the collision-induced dissociation of select beta blockers: Acebutolol, atenolol, bisoprolol, carteolol, and labetalol.
Topics: Acebutolol; Atenolol; Bisoprolol; Carteolol; Chromatography, Liquid; Labetalol; Tandem Mass Spectrometry | 2023 |